Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts

<div>Hematoxylin–eosin staining of CRC cell lines COLO 205, HCT 116, HT29, SW480, Caco-2 (G0), and their second passage in mice (P2) (10x objective).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts 